{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T02:23:21Z","timestamp":1794104601160,"version":"4.8.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007957","name":"Chongqing Municipal Education Commission","doi-asserted-by":"publisher","award":["KJQN202300421"],"award-info":[{"award-number":["KJQN202300421"]}],"id":[{"id":"10.13039\/501100007957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270271"],"award-info":[{"award-number":["82270271"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010822","name":"Chengdu Science and Technology Bureau","doi-asserted-by":"publisher","award":["2024-YF05-02013-SN"],"award-info":[{"award-number":["2024-YF05-02013-SN"]}],"id":[{"id":"10.13039\/501100010822","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2025ZNSFSC1548"],"award-info":[{"award-number":["2025ZNSFSC1548"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.cbi.2026.112350","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:41:34Z","timestamp":1790782894000},"page":"112350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A mushroom-derived bioactive compound, Vialinin A, attenuates doxorubicin-induced cardiotoxicity via SUCLG2-associated mitochondrial protection"],"prefix":"10.1016","volume":"440","author":[{"given":"Yunpeng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xintong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tangtian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huizhe","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2026.112350_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119527","article-title":"A comprehensive review on time-tested anticancer drug doxorubicin","volume":"278","author":"Sritharan","year":"2021","journal-title":"Life Sci."},{"issue":"22","key":"10.1016\/j.cbi.2026.112350_bib2","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1001\/jama.2013.6296","article-title":"Clinical ascertainment of health outcomes among adults treated for childhood cancer","volume":"309","author":"Hudson","year":"2013","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.cbi.2026.112350_bib3","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1186\/s40001-025-02674-5","article-title":"Exploring the effects of doxorubicin on survival rates in glioma patients: a comprehensive systematic review","volume":"30","author":"Mahboubi","year":"2025","journal-title":"Eur. J. Med. Res."},{"issue":"1","key":"10.1016\/j.cbi.2026.112350_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.31557\/APJCP.2025.26.1.5","article-title":"Emerging research and future directions on doxorubicin: a snapshot","volume":"26","author":"Sinha","year":"2025","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"issue":"1","key":"10.1016\/j.cbi.2026.112350_bib5","article-title":"Drug\u2010induced oxidative stress and toxicity","volume":"2012","author":"Deavall","year":"2012","journal-title":"J. Toxicol."},{"key":"10.1016\/j.cbi.2026.112350_bib6","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.yjmcc.2013.11.007","article-title":"Cardiomyocyte autophagy and cancer chemotherapy","volume":"71","author":"Li","year":"2014","journal-title":"J. Mol. Cellular Cardiol."},{"issue":"3","key":"10.1016\/j.cbi.2026.112350_bib7","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/j.2040-4603.2019.tb00082.x","article-title":"Doxorubicin\u2010induced cardiomyopathy in children","volume":"9","author":"Mancilla","year":"2019","journal-title":"Compr. Physiol."},{"issue":"1\u20132","key":"10.1016\/j.cbi.2026.112350_bib8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1023\/A:1015976430790","article-title":"Doxorubicin-induced apoptosis: implications in cardiotoxicity","volume":"234\u2013235","author":"Kalyanaraman","year":"2002","journal-title":"Mol. Cell. Biochem."},{"issue":"3","key":"10.1016\/j.cbi.2026.112350_bib9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/14737175.2018.1425617","article-title":"Immunotherapy for brain tumors: understanding early successes and limitations","volume":"18","author":"Lieberman","year":"2018","journal-title":"Expert Rev. Neurother."},{"issue":"1","key":"10.1016\/j.cbi.2026.112350_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/ejhf.654","article-title":"2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC committee for practice guidelines the task force for cancer treatments and cardiovascular toxicity of the european society of cardiology (ESC)","volume":"19","author":"Luis Zamorano","year":"2017","journal-title":"Eur. J. Heart Fail."},{"issue":"4","key":"10.1016\/j.cbi.2026.112350_bib11","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s12012-022-09721-1","article-title":"Doxorubicin-induced cardiotoxicity: an overview on pre-clinical therapeutic approaches","volume":"22","author":"Sheibani","year":"2022","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.cbi.2026.112350_bib12","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejca.2023.02.019","article-title":"Anthracycline-induced cardiotoxicity\u2014are we about to clear this hurdle?","volume":"185","author":"Dempke","year":"2023","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.cbi.2026.112350_bib13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10557-016-6711-0","article-title":"Anthracycline chemotherapy and cardiotoxicity","volume":"31","author":"McGowan","year":"2017","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"5","key":"10.1016\/j.cbi.2026.112350_bib14","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1200\/JCO.2005.02.3879","article-title":"Dexrazoxane-associated risk for acute myeloid leukemia\/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease","volume":"25","author":"Tebbi","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cbi.2026.112350_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1241225","article-title":"Targeting mitochondrial dynamics proteins for the treatment of doxorubicin-induced cardiotoxicity","volume":"10","author":"Chen","year":"2023","journal-title":"Front. Mol. Biosci."},{"issue":"9","key":"10.1016\/j.cbi.2026.112350_bib16","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41569-018-0059-z","article-title":"Mitochondrial quality control mechanisms as molecular targets in cardiac ageing","volume":"15","author":"Picca","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"issue":"7","key":"10.1016\/j.cbi.2026.112350_bib17","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1161\/CIRCRESAHA.119.314681","article-title":"Mitochondrial determinants of doxorubicin-induced cardiomyopathy","volume":"126","author":"Wallace","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.cbi.2026.112350_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1658493","article-title":"Mechanisms and advantages of natural derived small molecule compounds in the prevention and treatment of colorectal cancer: a review","volume":"16","author":"Liao","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cbi.2026.112350_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156783","article-title":"Natural products and ferroptosis: a novel approach for heart failure management","volume":"142","author":"Zhang","year":"2025","journal-title":"Phytomedicine"},{"issue":"2","key":"10.1016\/j.cbi.2026.112350_bib20","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3390\/ph18020248","article-title":"Withania somnifera ameliorates doxorubicin-induced nephrotoxicity and potentiates its therapeutic efficacy targeting SIRT1\/Nrf2, oxidative stress, inflammation, and apoptosis","volume":"18","author":"Mohmmed Hegab","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.cbi.2026.112350_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.850066","article-title":"TLRs-JNK\/NF-\u03baB pathway underlies the protective effect of the sulfide salt against liver toxicity","volume":"13","author":"Abdel-Latif","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.cbi.2026.112350_bib22","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1002\/ptr.7865","article-title":"Edible mushrooms as potential functional foods in amelioration of hypertension","volume":"37","author":"Rauf","year":"2023","journal-title":"Phytother Res."},{"key":"10.1016\/j.cbi.2026.112350_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.925387","article-title":"Fungal mushrooms: a natural compound with therapeutic applications","volume":"13","author":"Chugh","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"11","key":"10.1016\/j.cbi.2026.112350_bib24","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3390\/md22110520","article-title":"Marine fungi bioactives with anti-inflammatory, antithrombotic and antioxidant health-promoting properties against inflammation-related chronic diseases","volume":"22","author":"Papikinou","year":"2024","journal-title":"Mar. Drugs"},{"issue":"13","key":"10.1016\/j.cbi.2026.112350_bib25","doi-asserted-by":"crossref","first-page":"6974","DOI":"10.1021\/jf200461j","article-title":"Anticancer activities of thelephantin O and vialinin A isolated from Thelephora aurantiotincta","volume":"59","author":"Norikura","year":"2011","journal-title":"J. Agric. Food Chem."},{"issue":"5","key":"10.1016\/j.cbi.2026.112350_bib26","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1248\/bpb.31.831","article-title":"Vialinin A, a novel potent inhibitor of TNF-\u03b1 production from RBL-2H3 cells","volume":"31","author":"Onose","year":"2008","journal-title":"Biol. Pharm. Bull."},{"issue":"2","key":"10.1016\/j.cbi.2026.112350_bib27","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/jcmm.16180","article-title":"Ubiquitously specific protease 4 inhibitor\u2010vialinin a attenuates inflammation and fibrosis in S100\u2010induced hepatitis mice through Rheb\/mTOR signalling","volume":"25","author":"Xu","year":"2021","journal-title":"J. Cell Mol. Med."},{"issue":"2","key":"10.1016\/j.cbi.2026.112350_bib28","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.cellimm.2012.10.008","article-title":"Inhibitory effects of vialinin A and its analog on tumor necrosis factor-\u03b1 release and production from RBL-2H3 cells","volume":"279","author":"Onose","year":"2012","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.cbi.2026.112350_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155304","article-title":"Vialinin A alleviates oxidative stress and neuronal injuries after ischaemic stroke by accelerating Keap1 degradation through inhibiting USP4-mediated deubiquitination","volume":"124","author":"Mao","year":"2024","journal-title":"Phytomedicine"},{"issue":"8","key":"10.1016\/j.cbi.2026.112350_bib30","article-title":"Vialinin A, an antioxidant derived from edible mushrooms, prevents ocular inflammation","volume":"66","author":"McMahon","year":"2025","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.cbi.2026.112350_bib31","first-page":"1429","article-title":"Inhibition of USP4 attenuates pathological scarring by downregulation of the TGF-\u03b2\/Smad signaling pathway","volume":"20","author":"Zhang","year":"2019","journal-title":"Mol. Med. Rep."},{"issue":"8_Supplement_1","key":"10.1016\/j.cbi.2026.112350_bib32","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2025-6321","article-title":"Vialinin-A, an antioxidant isolated from edible mushroom thelephora vialis, inhibits colorectal cancer growth","volume":"85","author":"Lahori","year":"2025","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.cbi.2026.112350_bib33","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70358","article-title":"Indole\u20103\u2010Lactic acid inhibits doxorubicin\u2010induced ferroptosis through activating aryl hydrocarbon receptor\/nrf2 signalling pathway","volume":"29","author":"Lian","year":"2025","journal-title":"J. Cell Mol. Med."},{"issue":"6","key":"10.1016\/j.cbi.2026.112350_bib34","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.3390\/ijms26062434","article-title":"Kartogenin improves Doxorubicin-Induced cardiotoxicity by alleviating oxidative stress and protecting mitochondria","volume":"26","author":"Zhang","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2026.112350_bib35","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.freeradbiomed.2022.12.101","article-title":"SIRT3 promotes metabolic maturation of human iPSC-derived cardiomyocytes via OPA1-controlled mitochondrial dynamics","volume":"195","author":"Wang","year":"2023","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.cbi.2026.112350_bib36","doi-asserted-by":"crossref","first-page":"7712","DOI":"10.1038\/s41467-024-51746-3","article-title":"10-hydroxy-2-decenoic acid prevents osteoarthritis by targeting aspartyl \u03b2 hydroxylase and inhibiting chondrocyte senescence in male mice preclinically","volume":"15","author":"Geng","year":"2024","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.cbi.2026.112350_bib37","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1200\/JCO.1997.15.4.1318","article-title":"Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer","volume":"15","author":"Swain","year":"1997","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.cbi.2026.112350_bib38","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12951-022-01353-5","article-title":"Doxorubicin and CpG loaded liposomal spherical nucleic acid for enhanced Cancer treatment","volume":"20","author":"Deng","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"7","key":"10.1016\/j.cbi.2026.112350_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/jcp.70064","article-title":"The role of mitochondrial dynamics in doxorubicin\u2010induced disease: implications for therapy","volume":"240","author":"Yue","year":"2025","journal-title":"J. Cell. Physiol."},{"issue":"7","key":"10.1016\/j.cbi.2026.112350_bib40","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.3390\/pharmaceutics14071313","article-title":"Assessing drug-induced mitochondrial toxicity in cardiomyocytes: implications for preclinical cardiac safety evaluation","volume":"14","author":"Tang","year":"2022","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.cbi.2026.112350_bib41","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.tips.2022.10.003","article-title":"Mitochondrial quality control mechanisms as therapeutic targets in doxorubicin-induced cardiotoxicity","volume":"44","author":"Wu","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"issue":"51","key":"10.1016\/j.cbi.2026.112350_bib42","doi-asserted-by":"crossref","first-page":"E5537","DOI":"10.1073\/pnas.1414665111","article-title":"Bnip3 mediates doxorubicin-induced cardiac myocyte necrosis and mortality through changes in mitochondrial signaling","volume":"111","author":"Dhingra","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"17","key":"10.1016\/j.cbi.2026.112350_bib43","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.3390\/nu17172838","article-title":"Protective role of key micronutrients in chemotherapy-induced organ toxicity: a comprehensive review of mechanistic insights and clinical implications","volume":"17","author":"Konstantinidis","year":"2025","journal-title":"Nutrients"},{"issue":"35","key":"10.1016\/j.cbi.2026.112350_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202303535","article-title":"SUCLG2 regulates mitochondrial dysfunction through succinylation in lung adenocarcinoma","volume":"10","author":"Hu","year":"2023","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.cbi.2026.112350_bib45","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/s41420-025-02856-4","article-title":"Knockdown of SUCLG2 inhibits glioblastoma proliferation and promotes apoptosis through LMNA acetylation and the mediation of H4K16la lactylation","volume":"11","author":"Li","year":"2025","journal-title":"Cell Death Discov."},{"issue":"1","key":"10.1016\/j.cbi.2026.112350_bib46","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41419-025-07856-x","article-title":"CircPSD3 aggravates tumor progression by maintaining TCA cycle and mitochondrial function via regulating SUCLG2 in thyroid carcinoma","volume":"16","author":"Sun","year":"2025","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.cbi.2026.112350_bib47","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s41936-021-00251-w","article-title":"Polyphenolic-enriched olive leaf extract attenuated doxorubicin-induced cardiotoxicity in rats via suppression of oxidative stress and inflammation","volume":"82","author":"Hamza","year":"2021","journal-title":"J. Basic Appl. Zool."},{"issue":"2","key":"10.1016\/j.cbi.2026.112350_bib48","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2174\/0113892010303097240605105013","article-title":"Cardioprotective potential of Moringa oleifera leaf extract loaded niosomes nanoparticles-against doxorubicin toxicity in rats","volume":"26","author":"Mohamad","year":"2025","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"7","key":"10.1016\/j.cbi.2026.112350_bib49","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1002\/ptr.8525","article-title":"Biochanin a alleviated doxorubicin\u2010induced cardiotoxicity but did not interfere with the antitumor effect of doxorubicin","volume":"39","author":"Yang","year":"2025","journal-title":"Phytother Res."},{"issue":"18","key":"10.1016\/j.cbi.2026.112350_bib50","doi-asserted-by":"crossref","first-page":"5909","DOI":"10.3390\/molecules27185909","article-title":"Binding of vialinin A and p-Terphenyl derivatives to ubiquitin-specific protease 4 (USP4): a molecular docking study","volume":"27","author":"Bailly","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.cbi.2026.112350_bib51","doi-asserted-by":"crossref","DOI":"10.1177\/11795549241281932","article-title":"Unraveling the mechanism of action of ubiquitin-specific protease 5 and its inhibitors in tumors","volume":"18","author":"Wang","year":"2024","journal-title":"Clin. Med. Insights Oncol."},{"issue":"17","key":"10.1016\/j.cbi.2026.112350_bib52","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1016\/j.bmcl.2016.07.051","article-title":"Vialinin A and thelephantin G, potent inhibitors of tumor necrosis factor-\u03b1 production, inhibit sentrin\/SUMO-specific protease 1 enzymatic activity","volume":"26","author":"Yoshioka","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279726004588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279726004588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T01:29:15Z","timestamp":1794101355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279726004588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":52,"alternative-id":["S0009279726004588"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2026.112350","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A mushroom-derived bioactive compound, Vialinin A, attenuates doxorubicin-induced cardiotoxicity via SUCLG2-associated mitochondrial protection","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2026.112350","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112350"}}